Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
MDRX > SEC Filings for MDRX > Form 8-K on 10-Mar-2014All Recent SEC Filings

Show all filings for ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.

Form 8-K for ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.


10-Mar-2014

Changes in Registrant's Certifying Accountant, Financial St


Item 4.01 Changes in Registrant's Certifying Accountant

(a)

The Audit Committee (the "Audit Committee") of the Board of Directors of Allscripts Healthcare Solutions, Inc. (the "Company") has resolved to initiate a competitive process to review the appointment of the Company's independent registered public accounting firm for the year ending December 31, 2014.

In connection with this decision, on March 6, 2014, Ernst & Young LLP ("E&Y"), the Company's independent registered public accounting firm for the year ended December 31, 2013, informed the Company that it has declined to stand for re-election as the Company's independent registered public accounting firm for the year ending December 31, 2014.

The reports of E&Y on the Company's consolidated financial statements for the fiscal years ended December 31, 2013 and 2012 did not contain any adverse opinion or disclaimer of opinion and were not qualified or modified as to uncertainty, audit scope, or accounting principles. The audit reports of E&Y on the effectiveness of internal control over financial reporting as of December 31, 2013 and 2012 did not contain any adverse opinion, nor were they qualified or modified as to uncertainty, audit scope, or accounting principles.

During the fiscal years ended December 31, 2013 and 2012, and the subsequent interim period through March 5, 2014, there have been (i) no "disagreements" (as such term is defined in Items 304(a)(1)(iv) of Regulation S-K) between the Company and E&Y on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which disagreements, if not resolved to the satisfaction of E&Y, would have caused E&Y to make reference thereto in their reports on the consolidated financial statements for such years; and (ii) no "reportable events" (as such term is defined in Item 304(a)(1)(v) of Regulation S-K).

The Company has provided E&Y with a copy of the foregoing disclosures and requested that E&Y furnish the Company with a letter addressed to the Securities and Exchange Commission stating whether or not it agrees with the statements contained in this Item 4.01. A copy of E&Y's letter dated March 10, 2014 is attached as Exhibit 16.1 hereto.



Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

Exhibit No.      Description

16.1             Letter to the Securities and Exchange Commission from Ernst &
                 Young LLP dated March 10, 2014


  Add MDRX to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for MDRX - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.